Summary: CHD8, a gene associated with autism plays a significant role in oligodendrocyte development, researchers report.
Source: Cincinnati Children’s Hospital Medical Center.
New preclinical research shows a gene already linked to a subset of people with autism spectrum disorder is critical to healthy neuronal connections in the developing brain, and its loss can harm those connections to help fuel the complex developmental condition.
Scientists at Cincinnati Children’s Hospital Medical Center report in Developmental Cell their data clarify the biological role of the gene CHD8 and its protein CHD8 in developing oligodendrocytes, cells that form a protective insulation around nerves. The sheath supports neuronal connections in the brain and manifest themselves in white matter.
Although previous studies show disruptive mutations in CHD8 cause autism spectrum disorders (ASDs) and abnormalities in the brain’s white matter, the underlying biology has been a mystery.
The current study, published online June 18, shows that disruption of CHD8 hinders the production and maintenance of nerve insulation–harming the brain’s neuronal connections and contributing to white matter damage. In laboratory mouse models genetically engineered to not express the CHD8 protein in the oligodendrocytes, the animals exhibited behavioral anomalies and seizures, according to lead study investigator Q. Richard Lu, PhD, Division of Experimental Hematology and Cancer Biology.
“So far no treatment is available for autism patients with mutations in CHD8, one of the highest risk-susceptibility genes for autism,” Lu said. “Current studies are still at a very early stage in terms of therapeutic agents, but our findings present a potential strategy to restore the function of faulty CHD8-dependent processes.”
Scientists found the strategy by using a number of experimental procedures with mice, including ChIP-Seq analysis of specific DNA-binding sites in developing oligodendrocytes, which helped them unravel biological processes. Their data showed that CHD8 loss or mutation reduces the function of what is known as a histone methyltransferase, which helps activate target genes needed for oligodendrocyte development.
They then figured out that using an experimental compound (CPI-455), which inhibits a different molecule linked to CHD8 called histone demethylase, rescued the development of oligodendrocytes. This reversed white matter defects in CHD8-mutant mice and reduced neurological problems in the animals.
Lu said the findings suggest that modulating the activity of CHD8 and the molecules that control it has the potential to enhance the generation of neuronal insulation in people with ASDs. He also stressed it will be years before knowing if the research will translate to clinical care in patients.
Additional studies are needed to verify the current study’s findings, identify a suitable drug, and test its safety and effectiveness in laboratory models. Unlocking the Code
CHD8 functions in the cell nucleus. It essentially unlocks the double-helix structure in the nucleus that contains DNA and RNA coding molecules. This allows changes to the helix’s genetic and molecular composition that support the development of oligodendrocytes and nerve insulation by regulating levels of encoded gene products.
When mutations or loss of CDH8 occur, it results in harmful remodeling of molecular components in the helix (referred to as chromatin).
About this neuroscience research article
Funding: Funding support for the research came in part from: National Institutes of Health (R01NS072427, R01NS075243); the National Multiple Sclerosis Society (RG1508, NMSS RG-1501-02851); the CHARGE syndrome Foundation; the National Natural Science Foundation of China (81720108018); and the Fondation pour l’Aide à la Recherche sur la Sclérose en Plaques (ARSEP, 2014, 2015, 2017).
The study included collaboration from co-authors at the Key Laboratory of Birth Defects, Children’s Hospital of Fudan University, Shanghai, China; Sorbonne Université, UPMC University Paris and Inserm GH Pitié-Salpêtrière, Institut du Cerveau et de la Moelle Épinière, Paris, France; and the departments of Pediatrics and Human Genetics at the University of Michigan in Ann Arbor.
Source: Nick Miller – Cincinnati Children’s Hospital Medical Center Publisher: Organized by NeuroscienceNews.com. Image Source: NeuroscienceNews.com image is credited to Cincinnati Children’s. Original Research:Abstract for “Dual Requirement of CHD8 for Chromatin Landscape Establishment and Histone Methyltransferase Recruitment to Promote CNS Myelination and Repair” by Chuntao Zhao, Chen Dong, Magali Frah, Yaqi Deng, Corentine Marie, Feng Zhang, Lingli Xu, Zhixing Ma, Xinran Dong, Yifeng Lin, Scott Koenig, Brahim Nait-Oumesmar, Donna M. Martin, Laiman N. Wu, Mei Xin, Wenhao Zhou’Correspondence information about the author Wenhao ZhouEmail the author Wenhao Zhou, Carlos Parras, and Q. Richard Lu in Developmental Cell. Published June 18 2018 doi:10.1016/j.devcel.2018.05.022
Cite This NeuroscienceNews.com Article
[cbtabs][cbtab title=”MLA”]Cincinnati Children’s Hospital Medical Center “How Autism Associated Gene Affects the Brain.” NeuroscienceNews. NeuroscienceNews, 18 June 2018. <https://neurosciencenews.com/autism-genetics-brain-9377/>.[/cbtab][cbtab title=”APA”]Cincinnati Children’s Hospital Medical Center (2018, June 18). How Autism Associated Gene Affects the Brain. NeuroscienceNews. Retrieved June 18, 2018 from https://neurosciencenews.com/autism-genetics-brain-9377/[/cbtab][cbtab title=”Chicago”]Cincinnati Children’s Hospital Medical Center “How Autism Associated Gene Affects the Brain.” https://neurosciencenews.com/autism-genetics-brain-9377/ (accessed June 18, 2018).[/cbtab][/cbtabs]
Dual Requirement of CHD8 for Chromatin Landscape Establishment and Histone Methyltransferase Recruitment to Promote CNS Myelination and Repair
Highlights •Autism-associated CHD8 required for oligodendrocyte development and survival •Chromatin regulator CHD8 required for OPC proliferation and remyelination •CHD8-BRG1-CHD7 cascade regulates oligodendroglial lineage progression •CHD8 recruits KMT2 histone methyltransferase to promote oligodendrocyte development
Summary Disruptive mutations in chromatin remodeler CHD8 cause autism spectrum disorders, exhibiting widespread white matter abnormalities; however, the underlying mechanisms remain elusive. We show that cell-type specific Chd8 deletion in oligodendrocyte progenitors, but not in neurons, results in myelination defects, revealing a cell-intrinsic dependence on CHD8 for oligodendrocyte lineage development, myelination and post-injury remyelination. CHD8 activates expression of BRG1-associated SWI/SNF complexes that in turn activate CHD7, thus initiating a successive chromatin remodeling cascade that orchestrates oligodendrocyte lineage progression. Genomic occupancy analyses reveal that CHD8 establishes an accessible chromatin landscape, and recruits MLL/KMT2 histone methyltransferase complexes distinctively around proximal promoters to promote oligodendrocyte differentiation. Inhibition of histone demethylase activity partially rescues myelination defects of CHD8-deficient mutants. Our data indicate that CHD8 exhibits a dual function through inducing a cascade of chromatin reprogramming and recruiting H3K4 histone methyltransferases to establish oligodendrocyte identity, suggesting potential strategies of therapeutic intervention for CHD8-associated white matter defects.